BioCorRx Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $657.3K | $701.8K | $924.7K | $1.2M | $715.0K | $868.2K | $771.8K | $144.4K |
| Cost of Revenue | $323.6K | $175.4K | $152.0K | $221.0K | $160.2K | $402.5K | $400.4K | $156.2K |
| Gross Profit | $333.7K | $526.3K | $772.8K | $950.0K | $554.8K | $465.7K | $371.3K | $-11.8K |
| Gross Margin | 50.8% | 75.0% | 83.6% | 81.1% | 77.6% | 53.6% | 48.1% | -8.2% |
| Operating Expenses | ||||||||
| Research & Development | $450.7K | — | — | — | — | — | — | — |
| SG&A Expense | $2.7M | $2.5M | $2.1M | $3.9M | $2.9M | $1.1M | $713.6K | $119.9K |
| Operating Income | $-2.9M | $-2.2M | $-5.1M | $-3.1M | — | — | — | — |
| Operating Margin | -439.8% | -310.9% | -553.4% | -260.7% | — | — | — | — |
| Interest Expense | $11.1M | $1.0M | $377.1K | $352.8K | $310.4K | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | $1.6K | $1.6K | — | — |
| Net Income | $-29.7M | $-5.9M | $-4.7M | $-3.1M | $-3.8M | $-885.8K | $-409.0K | $-154.6K |
| Net Margin | -4,519.5% | -841.3% | -504.6% | -267.1% | -536.9% | -102.0% | -53.0% | -107.1% |
| EPS (Basic) | $-3.19 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $-3.19 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | — | — | — | — | 4.23B | 3.82B | 3.64B | 2.66B |
| Shares Outstanding (Diluted) | 7.3M | 1.00B | 964.6M | 647.3M | 568.8M | 3.82B | 3.64B | 2.66B |
| Dividends Per Share | — | — | — | — | — | — | — | — |